Bendamustine, Obinutuzumab and Venetoclax Results in High Complete Response Rates in Untreated Mantle Cell Lymphoma

Authors: Greenwell, Irl Brian, Switchenko, Jeffrey M. ^*, Craig, Alexander F.M., Alizadeh, Ash A., Allen, Pamela B., Escobar, Alicia ^*, Valla, Kelly ^*, Abousaud, Aseala ^*, Parikh, Priya ^*, Roberts, Danielle ^*, Neely, Jessica J. ^*, Palmer, Alexandra ^*, Blum, Kristie A., Cohen, Jonathon B., Algave, Marcela ^*

Source: In Blood 15 November 2022 140 Supplement 1:9373-9374

Bendamustine, Obinutuzumab and Venetoclax As Induction Therapy for Untreated Mantle Cell Lymphoma

Authors: Greenwell, Irl Brian, Switchenko, Jeffrey M. ^*, Maddocks, Kami J., Kahl, Brad S., Craig, Alexander F.M., Alizadeh, Ash A., Allen, Pamela B., Marbury, Alena Lorretta ^*, Escobar, Alicia ^*, Valla, Kelly ^*, Williams, Miayea ^*, Parikh, Priya ^*, Roberts, Danielle ^*, Neely, Jessica J. ^*, Palmer, Alexandra ^*, Blum, Kristie A., Cohen, Jonathon B.

Source: In Blood 5 November 2020 136 Supplement 1:33-34